Clinical trial
The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host…
NCT00141713 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00141713 |
|---|---|
| Title | The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease |
| Official title | The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft-Versus-Host Disease |
| Intervention type | Drug |
| Interventions | Etanercept |
| Enrollment | 40 |
| Start date | Oct 1, 2003 |
| Primary completion | Nov 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 1, 2005 |
| Last update posted | Mar 13, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: